Scholars Central

OpinionPublished 26 Nov 2025

Risk-Based HPV Management Transforms Cervical Dysplasia

Authors: Aamir Khan

Cancer Research Institute, Lahore, Pakistan

Cervical Cancer: Open Access

Volume 10 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cervical dysplasia management is evolving with 2023 ASCCP risk-based guidelines, personalizing care for intraepithelial neoplasia and high-grade lesions. Primary HPV screening demonstrates superior detection, while emerging technologies and biomarkers enhance diagnosis and prognosis. Immunotherapies offer new treatment avenues. Global screening disparities highlight the need for equitable HPV vaccination and follow-up. Understanding HPV’s natural history and addressing vaccine uptake barriers are crucial for effective prevention. Managing abnormal cytology in pregnancy balances maternal and fetal health, often deferring treatment for high-grade lesions until postpartum.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cervical Cancer: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCervical Cancer: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Aamir Khan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels